Back to top
more

IDEXX Laboratories (IDXX)

(Real Time Quote from BATS)

$420.37 USD

420.37
364,788

-3.28 (-0.77%)

Updated Nov 15, 2024 03:04 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (65 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks.com featured highlights include: IDEXX Laboratories, AGCO, D.R. Horton and MSCI

by Zacks Equity Research

Zacks.com featured highlights include: IDEXX Laboratories, AGCO, D.R. Horton and MSCI

Nevro (NVRO) Posts Weak Preliminary Q4 and 2020 Revenues

by Zacks Equity Research

Nevro's (NVRO) preliminary worldwide Q4 revenues are expected to decline from the year-ago quarter's figure.

Abbott (ABT) to Expand in Booming TBI Space on New Approval

by Zacks Equity Research

If positive, Abbott's (ABT) TBI blood test result complements CT scans to help evaluate whether a suspected patient has a TBI.

Phirbo (PAHC) Nutritional Specialty Aids Growth, Low ASP Ails

by Zacks Equity Research

Phirbo's (PAHC) net vaccine sales remain robust on higher international demand for poultry vaccines.

Here's Why You Should Invest in LHC Group (LHCG) Stock Now

by Zacks Equity Research

LHC Group (LHCG) continues to gain traction from its broad range of services, and strategic acquisitions and joint ventures.

AMN Healthcare (AMN) Releases Solid Preliminary Q4 Revenues

by Zacks Equity Research

AMN Healthcare (AMN) posts solid fourth-quarter 2020 revenue data on the back of strong demand for the company's services across its three segments.

Myriad Genetics (MYGN), Illumina Partner to Enhance Oncology Arm

by Zacks Equity Research

Myriad Genetics (MYGN) partners with Illumina to expand the access as well as extend the reach of myChoice CDx through its services offering in the international market.

Tirthankar Chakraborty headshot

4 of the Best Stocks to Buy for Solid Earnings Growth in 2021

by Tirthankar Chakraborty

Earnings growth is considered the most important variable in influencing the share price. Notably, some of the stocks that boast of superb earnings growth include D.R. Horton (DHI) and MSCI.

Hologic (HOLX) Hits a New 52-Week High: What's Driving It?

by Zacks Equity Research

Investors are optimistic about Hologic's (HOLX) impressive preliminary results for the first quarter of fiscal 2021 and regulatory approvals.

Illumina (ILMN), Helix Partner to Develop Tracking Setup in U.S.

by Zacks Equity Research

Illumina (ILMN) collaborates with Helix with support from the CDC to set up an enhanced surveillance infrastructure to track the emergence and prevalence of B.1.1.7.

National Vision (EYE) Rides on Comps Growth Amid COVID-19 Woes

by Zacks Equity Research

National Vision's (EYE) Eyeglass pumps sales are robust driven by increases in both customer transactions and average ticket.

Why You Must Add Merit Medical (MMSI) Stock to Your Portfolio

by Zacks Equity Research

Investor optimism is high on Merit Medical (MMSI) stock, courtesy of solid prospects.

Hologic (HOLX) Rides on Robust Preliminary Q1 Organic Sales

by Zacks Equity Research

The uptick in Hologic's (HOLX) Diagnostics sales is likely the result of increased demand for COVID-19 testing.

AngioDynamics (ANGO) Q2 Earnings and Revenues Top Estimates

by Zacks Equity Research

AngioDynamics (ANGO) witnesses revenue growth across two business segments in fiscal Q2.

Hologic (HOLX) to Expand in Oncology With Biotheranostics Buyout

by Zacks Equity Research

Hologic (HOLX) aims to strengthen its Diagnostics business by foraying into the oncology adjacency space via the acquisition of Biotheranostics.

Walgreens Boots (WBA) Q1 Earnings Top Estimates, Margins Down

by Zacks Equity Research

Walgreens Boots' (WBA) fiscal first-quarter results reflect overall top-line improvement despite COVID-19-led business disruptions.

Cardinal Health (CAH) Unveils New Logistics Management Tool

by Zacks Equity Research

Cardinal Health's (CAH) company, OptiFreight Logistics, launched TotalVue Analytics to help healthcare supply chain leaders to drive cost savings.

NEOGEN (NEOG) Fortifies Global Position via Megazyme Buyout

by Zacks Equity Research

NEOGEN's (NEOG) buyout of Megazyme is expected to strengthen its Food Safety business worldwide.

Zimmer Biomet (ZBH) Shows Strong APAC Recovery, EMEA Slow

by Zacks Equity Research

Zimmer Biomet (ZBH) is performing well in its priority areas like quality remediation, supply recovery efforts and product introductions.

Henry Schein (HSIC) Grows Inorganically, Closes JV, Buys Stake

by Zacks Equity Research

The developments are expected to strengthen Henry Schein's (HSIC) presence in high potential and still-untapped markets.

Hologic (HOLX) Completes SOMATEX Buyout, Expands Portfolio

by Zacks Equity Research

Hologic (HOLX) to expand biopsy portfolio as well as enhance patient experience via the SOMATEX buyout.

DENTSPLY (XRAY) Acquires Byte to Boost Clear Aligner Business

by Zacks Equity Research

DENTSPLY (XRAY) acquires Byte to strengthen presence in the lucrative clear aligner space.

Here's Why You Should Retain Cardinal Health (CAH) Stock Now

by Zacks Equity Research

Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment, diversified product portfolio and buyouts.

Here's Why You Should Hold on to Medtronic (MDT) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about Medtronic (MDT) on slew of product launches and regulatory approvals.

NextGen's (NXGN) Platform Gets Adopted by FPA Women's Health

by Zacks Equity Research

FPA Women's Health utilizes NextGen's (NXGN) Virtual Visits, which are integral to the company's Patient Experience Platform